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Adopted by the Polish Society of Endocrinology and the
Polish Thyroid Association American system of the classi-
fication of FNAB cytological smears - the Bethesda System
for Reporting Thyroid Cytopathology (TBSRTC) deter-
mines exactly how to run diagnostics and therapy for each
category of smears. Cytopathologist establishing a diagno-
sis should provide it in such a way as to include a detailed
description of both the observed specimen [existing types
of cells, their abundance (their number) and the spatial
arrangements (layouts) which they form, as well as other
components of the smear, such as, e.g. colloid protein
masses] and a diagnostic conclusion which assigns a
smear to one of six (6) categories TBSRTC. In order to
avoid unintentional mistake during the process of assign-
ing in question, the endocrinologists should have a basic
idea of what kind cellular and/or acellular components
determine and prejudge the qualification of cytological
smear to a specific TBSRTC category. It should be noted
that having this skill is not to control the description of
cytological result as morphological diagnostics (within the
meaning of the direct microscopic evaluation of slides) is
beyond the reach of an endocrinologist and other doctors
who are not cytopathologists, just check whether there is
compliance of the diagnostic conclusion and morphologi-
cal description of the smear, because it is TBSRTC cate-
gory which decisively determines further medical
management. As shown by us in the proposed algorithm,
the assignment of the specimen to each category, together
with, the so-called, US risk pattern (which is defined in a
3-stage as a pattern of high, intermediate or low risk) are
decisive for the recommendation of surgical treatment or
abandonment of such treatment and further follow up;
they also are decisive as regards the frequency of repeat
US and FNAB cytology. Thus, the essence of the present
lecture is to familiarize endocrinologists with the signifi-
cance of individual components of the smear, as described
in cytology, in determining the appropriate TBSRTC cate-
gory. In practice, the most important issue is to properly
differentiate categories II, III and IV, because there is little
doubt as regards treatment of patients with other smear
categories (I, V and VI). Therefore, it is necessary to
remember that the normotypic thyroid follicular cells (tfc),
both dispersed and arranged in large and/or medium-
sized spatial patches and groups, and sometimes nests, are
characteristic rather for benign lesions. On the other hand,
small spatial layouts, especially arrangements of rosettes
type are characteristic for category IV (follicular neoplasm
or suspicious for a follicular neoplasm). It should be
added, however, that large spatial layouts may also be pre-
sent in papillary thyroid carcinoma; undoubted help in
case of detection of this cancer is, however, characteristic
appearance of cells and their typical cytological features.
Cytological smears obtained from benign lesions may con-
tain cells with different abundance, and also a variety of
other cells can be the smear components, such as, e.g.
cells typical for inflammatory processes (lymphocytes, neu-
trophils, multi- and mononucleated macrophages), aniso-
cytosis is frequently observed (sometimes anisocaryosis),
and - which is particularly characteristic - considerable
quantities of colloid are present in the smear. In contrast
to the above components, “follicular neoplasm” in cytolo-
gical smear has no colloid at all or its trace amount,
monomorphic tfc occurring usually in large numbers and
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arranged in small layouts, which characteristically take the
form of the, so-called, rosettes. Anisocytosis generally does
not occur, cell types other than monomorphic tfc and lar-
ger spatial arrangements are very rare. In case of smears
collected from oncocytic lesions, the assignment to the
category IV is determined by the percentage of oncocytes
in the smear (above 75%). Oncocytic cells should have
described the presence of nucleoli, anisocytosis may occur
in this case and spatial arrangements can be of any type.
Finally, it is noted that smears of category III, called by
some authors as “a category of exclusion”, contain both
components characteristic for category II and may also
include elements of morphological smears of category IV,
but in a such proportion that would not allow to categori-
cally qualify them as benign lesions or as “a suspicion of
follicular neoplasm”.
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